SurGenTec
2020 Orthopedics This Week Spine Technology Award Goes to SurGenTec
Travis Greenhalgh, CEO of SurGenTec stated in a recent interview, “This award is a great honor for our company. We pride ourselves on developing new technologies to help physicians treat their patients with less-invasive treatment options."
SurGenTec
3D GraftRasp System Including Spine Indications Receives FDA 510(k) Clearance – Approved for General Orthopedic Use and Spine Proccedures
The 3D GraftRasp System is the only device to receive FDA clearance that allows for both decortication of bone and the delivery of autograft, allograft or synthetic bone graft.
SurGenTec
Neurostimulation with ALARA™ Access Needle Kit Receives FDA Clearance
he ALARA system is used for targeting and assisting in cannulating a pedicle. Targeting needles are generally the first instrument used to perforate the pedicle wall before advancing a guidewire, tap or pedicle screw.
SurGenTec
SurGenTec’s GRAFTGUN Receives Key Patent
SurGenTec®, a minimally invasive orthobiologics company, has announced that the United States Patent and Trademark Office has granted a new patent for its bone graft delivery technology.
The proprietary GRAFTGUN® delivery system enables surgeons to deliver the bone...
